Cygnus Medicare Private Limited

About Cygnus Medicare Private Limited bond with ISIN: INE09KQ07012

In the competitive landscape of fixed income securities, detailed and comprehensive information is vital for both investors and market analysts. This bond, identified by the unique ISIN INE09KQ07012, represents a significant financial instrument. Issued by CYGNUS MEDICARE PRIVATE LIMITED, it comes with the following description: "MIBOR LINKED SECURED UNRATED UNLISTED REDEEMABLE NON-CONVERTIBLE DEBENTURE SERIES 1 DATE OF MATURITY 24/12/2031.". Although the bond is currently marked as active, its structure and historical context provide valuable insights into the world of debentures and non-convertible securities. The issuer, CYGNUS MEDICARE PRIVATE LIMITED, classified as Non PSU, plays an essential role in the market despite some details such as sector, industry, and issuer nature not being explicitly provided. Key identifiers like the Corporate Identification Number (CIN) U85190HR2011PTC064120 further bolster its credibility. With a coupon rate of Mibor, this instrument has been meticulously managed with the assistance of Zuari Investments Limited and under the oversight of Catalyst Trusteeship Limited (Formerly GDA Trusteeship Limited), ensuring a strong operational framework. Examining the technical specifications, the bond’s face value is 1000000 with an issue size of 43. It was allotted on 12/24/2024 and is scheduled for redemption on 12/24/2031. Categorized under "PLAIN VANILLA DEBENTURES" and defined as Secured, the instrument is structured to meet specific investment objectives. Although options such as call or put are not applicable in this instance, the core attributes remain detailed and robust. A critical element in evaluating any fixed income instrument is its credit rating. No credit rating information is available for this bond. This insight helps potential investors understand that while the ratings spectrum is broad, a lower rating can indicate higher risk, prompting careful consideration before investing. The security measures add another layer of assurance. The asset cover is described as follows: First Ranking Exclusive Charge on certain identified movable fixed assets of the Company, as mutually agreed between the Original Debenture Holder and the Company pursuant to Deed of Hypothecation to be executed between Catalyst Trusteeship Limited and the Company. – a feature that, while requiring further inquiry for complete details, underscores the issuer’s commitment to providing some level of investor protection. Furthermore, the bond is supported by several documents. There are no additional documents available for this bond. These documents serve as a reference for additional details and provide transparency to interested parties. No similar bonds are listed at this time. Such comparable instruments offer a broader perspective on market positioning and allow investors to perform benchmark analysis. This detailed description is crafted to meet rigorous content standards and to offer exhaustive insights into every facet of the bond’s structure. Investors, analysts, and researchers alike can derive substantial value from this narrative, which underscores both the instrument’s inherent characteristics and its broader market positioning. Such elaborate coverage enhances investor confidence by providing a rich, comprehensive content base. Every element from issuance details to security measures and comparative insights is meticulously presented to facilitate an informed and robust market understanding.